OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
While plan managers have been doing it for nearly two decades with oral medications that are paid on the pharmacy benefit, the product-preferencing process is relatively novel for injectable medications. The next natural discussion is the role of benefit designs in the management of the cost of injectable products, since this is closely tied to product preferencing.